Sonrotoclax
N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
Molecular Identity
Sonrotoclax
N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
PubChem CID: 149553242
2D Structure
Properties
C49H59N7O7S
Molecular Formula
890.10
Molecular Weight
g/mol
889.4197
Exact Mass
Da
9.1
XLogP
Above Lipinski threshold
194
TPSA
May have limited oral absorption
4
H-Bond Donors
11
H-Bond Acceptors
1700
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Sonrotoclax2383086-06-2BGB-11417BGB1141730R67U9KYSBgb 11417N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide98Isonrotoclax [INN]Sonrotoclax [WHO-DD]Sonrotoclax (USAN/INN)SONROTOCLAX [USAN]orb1982765CHEMBL5314951CHEMBL5560668
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Sonrotoclax
Loading drug network...